This is consistent with previous roles described for AXL inhibition in blocking the DNA damage response and increasing sensitivity to PARP inhibitors (Ramkumar et al., 2021), as well as for JNK activation as necessary for CIN tolerance (Wong et al., 2014). Here, MAPK8 is linked to cervical squamous intraepithelial neoplasia.